Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

NCT01090713 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Binge Eating Disorder

Interventions

DRUG: lisdexamfetamine
DRUG: Placebo control

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]
[object Object]